Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • duckduffer duckduffer Feb 22, 2013 12:00 PM Flag

    Pretty Encouraging CC

    If you have a investment time horizon of more than a week or month, the call was IMO pretty solid.
    -2 Additional Phase 3 Trials in RCC & HCC for Cometrique w/FDA and EU approved trial designs
    - Ended 2012 with $637 Million in Cash
    - Expect to end 2013 with over $400 Million in Cash
    - Comet trials still on track to read out in 2014
    Anyone concerned about the revenue miss is simply in the wrong sector. I'm pretty happy with what I heard yesterday and looking to add a little in this price range.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "Anyone concerned about the revenue miss is simply in the wrong sector"
      Right
      This is not a profitable Company, not yet.
      So who cares for that -0.06?
      When it starys the big sales era, then we'll look closer to the EPS.
      At this point, EXEL is still in the "bonds & projections" mode.
      Today is only speculation.
      Let them play.

      We'll see who laugh when trial data are out..... and BPs' interest grows.

 
EXEL
3.15+0.04(+1.29%)Apr 20 4:00 PMEDT